Musculoskeletal Oncology

Musculoskeletal Oncology involves care for patients with benign and malignant bone and soft tissue tumors. This includes patients from newborns to the elderly. This also includes patients with metastatic disease to bone that has spread from another form of primary cancer. Musculoskeletal oncology care involves a multidisciplinary team approach, as patients with these conditions may also require chemotherapy, radiation therapy, and pathology review for an accurate diagnosis and treatment. Additionally, patients with these conditions often benefit from the involvement of other surgical specialties, including plastic surgery and general surgery, to ensure the highest level of care possible. By collaborating with other experts within the Rutgers system, the MSO division provides patients with access to the most modern treatments and clinical trials available.

Dr. Joseph Benevenia is a fellowship trained musculoskeletal oncologist and Chair of the Department of Orthopaedics at Rutgers, New Jersey Medical School. He has also served previously as the Rutgers NJMS Orthopaedic residency program director. He is a past president of the Musculoskeletal Tumor Society (MSTS) and serves as a member of numerous national and international societies to advance musculoskeletal oncology care worldwide. Dr. Benevenia’s clinical and research interest include orthopaedic implant design and innovation, treatment of bone and soft-tissue tumors, and limb-salvage surgeries.

Dr. Kathleen Beebe is a fellowship trained musculoskeletal oncologist and Professor for the Department of Orthopaedics at Rutgers New Jersey Medical School. She has also served previously as the Rutgers NJMS Orthopaedic residency program director. Dr. Beebe is an active member of the Ruth Jackson Orthopaedic Society and remains an active member of the Musculoskeletal Tumor Society (MSTS) and advocate for wellness and equity in the workplace. As a former physical therapist, Dr. Beebe maintains unique perspective in improving patient function after surgical treatment.

Dr. Joseph Ippolito is a fellowship trained musculoskeletal oncologist and Assistant Professor for the Department of Orthopaedics at Rutgers New Jersey Medical School. After completing his fellowship training at the University of Chicago, he returned to his home state of New Jersey to continue to care for patients. Dr. Ippolito is an active research contributor to national and international societies to advance the care of musculoskeletal oncology patients. As a cancer survivor, Dr. Ippolito maintains a unique perspective of patient-centered, compassionate care. Dr. Ippolito’s research and clinical interests include implant design and innovation, treatment of pediatric and adult patients with bone and soft tissue tumors, care for metastatic disease to bone, limb-salvage, and total joint arthroplasty.

Dr. Benevenia, Dr. Beebe and Dr. Ippolito are all fellowship trained and well-recognized experts in the treatment of Musculoskeletal tumors.  Together with a Musculoskeletal tumor team, they provide state of the art care for patients with often life-threatening problems across the state of New Jersey and are credentialed at University Hospital in Newark, Cooperman Barnabas Medical Center, Robert Wood Johnson University Hospital, and Newark Beth Israel Medical Center. They specialize in limb-salvage and limb-sparing procedures for the treatment of tumors in both the adult and pediatric patient.  They have utilized new techniques for preserving limb growth in pediatric patients after tumor treatment. In addition, they also treat complex salvage of failed total joint arthroplasty and aggressive Musculoskeletal infections with bone destruction.

Office Locations:
205 S. Orange Avenue, Suite 1200, Newark, NJ 07013
200 S. Orange Avenue, Suite 150, Livingston, NJ 07601
195 Little Albany St., New Brunswick, NJ 08901
233 Millburn Avenue, Millburn, NJ 07041